Premium
Rolling review: gastrointestinal malignancy
Author(s) -
LUK G. D.
Publication year - 1993
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.1993.tb00149.x
Subject(s) - medicine , gastrointestinal cancer , chemotherapy , malignancy , colorectal cancer , cancer , adjuvant chemotherapy , oncology , adjuvant , intensive care medicine , multidisciplinary team , nursing , breast cancer
SUMMARY The chemotherapy of gastrointestinal malignancies remain mostly investigational, although several adjuvant protocols in colorectal cancer and anal cancer are beginning to be accepted as standards against which newer regimens are to be compared. Chemotherapy regimens are best understood and appreciated with a basic understanding of cancer biology, tumour cell kinetics, and drug toxicities. An appreciation of chemotherapy‐induced toxicity and an awareness of their management will help the gastroenterologist be an active participant in the multidisciplinary team caring for the patient with gastrointestinal malignancies.